What a week! Thanks to all of our customers, colleagues, friends, media partners, @nasdaq and others for the messages on our company news. As Dr. Hyde said: "Much more to come" Check out our full list of media coverage here: https://lnkd.in/eEfQFiCE
A big day for Atropos Health yesterday. As the Gen AI hype bubble in Healthcare begins to shift, the focus is going to be on Quality, Accuracy, and Transparency. The core of Atropos is producing high-quality research-grade evidence with great automation and speed paired with quality, accuracy, and transparency physicians and researchers can trust. By doing this we are beginning to solve the Evidence Gap that has hampered effective clinical decision-making. The 40-year dream of a learning health system and personalized evidence-based medicine is feeling closer every day. Come and join us in this mission, and reach out to find out how Atropos is building infrastructure and user experiences that can be leveraged by all stakeholders in the healthcare ecosystem. A special thanks to my cofounders Nigam Shah and Saurabh Gombar for your shared vision and incredible partnership. Also to our Day 1 team members who have led the approach to building this amazing platform Neil Sanghavi Yen Sia Low, PhD Vladimir Polony Rehan Chawdry Uday Reddy Alison Callahan. Also to all of our Day 1 investors, but in particular Matt Bettonville and Jim Breyer for your leadership and guidance. Lastly, a big welcome to our new investors and partners Mike Spadafore Joel Krikston Kindra Tatarsky Michelle Snyder and Corey Lenhoff. It is incredibly exciting to have such a strong group of partners including Valtruis McKesson Ventures Cencora Merck at the table with us for this next phase. Stay tuned, much more to come.
